rediff.com
e.g. Tata motors, Reliance MF, 500570
Sudarshan Pharma Industries Ltd. - Research Center
543828 SUDARSHAN Group (MT) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 465.56 461.33 357.09 193.35 147.98
Expenses
Material consumed 424.53 430.95 335.11 177.59 136.86
Manufacturing expenses 9.09 8.13 5.52 1.70 1.01
Personnel expenses 3.50 2.98 2.43 1.62 1.60
Selling expenses 0.03 0.01 - 0.01 0.03
Adminstrative expenses 5.81 4.58 3.11 5.24 3.88
Expenses capitalised - - - - -
Cost of sales 442.96 446.64 346.17 186.17 143.37
Operating profit 22.60 14.69 10.92 7.18 4.61
Other recurring income 2.75 1.12 0.46 0.27 0.02
Adjusted PBDIT 25.36 15.81 11.38 7.45 4.63
Financial expenses 9.03 5.40 3.38 3.13 2.57
Depreciation 1.23 0.91 0.87 0.74 0.35
Other write offs - - - - -
Adjusted PBT 15.10 9.50 7.14 3.58 1.72
Tax charges 3.74 2.46 1.89 0.90 0.44
Adjusted PAT 11.36 7.04 5.25 2.67 1.28
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 11.36 7.04 5.25 2.67 1.28
Earnigs before appropriation 30.46 19.11 12.07 6.81 4.14
Equity dividend 0.72 - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 29.74 19.11 12.07 6.81 4.14
Close
Add Sudarshan Pharma Industries Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Sudarshan Pharma Industries Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close